• Latest Posts

A new treatment for tackling epidermolysis bullosa

Prurigo nodularis treatment recommended for EU approval  

Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo

Treatment for adults with chronic skin condition approved by FDA

Kamari Pharma raises $8M in investment for development of drugs for skin diseases

Regeneron and Sanofi announce published trial results in children with dermatitis


Ilya Pharma partners with US Defense Department for wound healing drug

Treatment for adults with moderate to severe psoriasis approved by FDA

Lutris Pharma radiation trial brings positive results for breast cancer patients

Arcutis Biotherapeutics acquires Ducentis BioTherapeutics in deal worth up to $400M

Psoriasis pustules disappear in over half of patients using Boehringer Ingelheim drug

Ilya Pharma finalizes global patent coverage for modified lactic acid bacteria to treat wounds